Payal Sahni - Feb 28, 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: Susan E. Grant, by power of atty., for Payal Sahni
Stock symbol: PFE
Transactions as of: Feb 28, 2022
Transactions value $: -$49,240
Form type: 4
Date filed: 3/1/2022, 04:55 PM
Previous filing: Feb 25, 2022
Next filing: May 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	-$49.2K	-1.05K	-5.3%	$46.94	18.8K	Feb 28, 2022	Direct	F1
holding	PFE	Common Stock						9.72K	Feb 28, 2022	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Phantom Stock Units	Award	$0	+4.3K		$0.00	4.3K	Feb 28, 2022	Common Stock	4.3K		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2	Each unit represents one phantom share of common stock.
F3	The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
F4	The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.